# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Maxim Group analyst Anthony Vendetti initiates coverage on Nutex Health (NASDAQ:NUTX) with a Buy rating and announces Price ...
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, healthcare delivery system ...
Benchmark analyst Bill Sutherland maintains Nutex Health (NASDAQ:NUTX) with a Buy and raises the price target from $30 to $45.
Nutex Health (NASDAQ:NUTX) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.29) ...
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, technology-enabled integrat...
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), today announced a 1-for-10 reverse stock spl...
Nutex Health a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro h...
- SEC Filing